By monika singh | 29 Mar, 2022
Anupam Rasayan rating – Buy: Earnings prospects for company are strong
Anupam Rasayan (ARL) is well-positioned to benefit from ‘China 1’ with its diversified chemistry expertise, wide customer base and presence across multiple verticals. Strong LT contract pipeline offers medium-term growth visibility. We forecast Rev/Ebitda/PAT CAGR of 33%/29%/31% over FY22-24e. Valuation is favourable after a 16% correction. We initiate at Buy with a Rs 1,040 PT at 38x P/E on...
Live Comments
blogist01 2022-07-13 11:41:51
dii brought 39% stack in last 3 month super rocket.
Login & Reply Like(0) Dislike(0) Repost Spam